ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.331,39
-0,25%
S&P 500
5.469,30
0,39%
US Dollar vs BRL
5,4522
0,00%
Bitcoin
61.941,13
0,22%
Brent Oil
84,655
0,56%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. TScan Therapeutics Inc (TCRX)

  7. TScan Therapeutics Inc (TCRX) Notícias

TCRX

TScan Therapeutics (TCRX)

TScan Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:TCRX
DataHoraFonteTítuloCódigoCompanhia
14/06/202417:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TCRXTScan Therapeutics Inc
14/06/202417:05Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TCRXTScan Therapeutics Inc
14/06/202408:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRXTScan Therapeutics Inc
14/06/202408:00GlobeNewswire Inc.TScan Therapeutics Announces Updates to its Board of DirectorsNASDAQ:TCRXTScan Therapeutics Inc
30/05/202408:00GlobeNewswire Inc.TScan Therapeutics Announces Upcoming Presentation at the Jefferies Global Healthcare ConferenceNASDAQ:TCRXTScan Therapeutics Inc
29/05/202408:00GlobeNewswire Inc.TScan Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for its Two Lead TCR-T Therapy Candidates for the Treatment of Heme MalignanciesNASDAQ:TCRXTScan Therapeutics Inc
13/05/202408:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TCRXTScan Therapeutics Inc
13/05/202408:00GlobeNewswire Inc.TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:TCRXTScan Therapeutics Inc
09/05/202408:00GlobeNewswire Inc.TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid TumorsNASDAQ:TCRXTScan Therapeutics Inc
24/04/202417:05GlobeNewswire Inc.TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual MeetingNASDAQ:TCRXTScan Therapeutics Inc
24/04/202412:03GlobeNewswire Inc.TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional SharesNASDAQ:TCRXTScan Therapeutics Inc
22/04/202418:01GlobeNewswire Inc.TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual MeetingNASDAQ:TCRXTScan Therapeutics Inc
19/04/202411:05GlobeNewswire Inc.TScan Therapeutics Announces Closing of Upsized Public OfferingNASDAQ:TCRXTScan Therapeutics Inc
17/04/202401:30GlobeNewswire Inc.TScan Therapeutics Announces Pricing of Upsized $150 Million Public OfferingNASDAQ:TCRXTScan Therapeutics Inc
16/04/202417:25GlobeNewswire Inc.TScan Therapeutics Announces Launch of $125 Million Proposed Public OfferingNASDAQ:TCRXTScan Therapeutics Inc
16/04/202417:01GlobeNewswire Inc.TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term PrioritiesNASDAQ:TCRXTScan Therapeutics Inc
08/04/202409:00GlobeNewswire Inc.TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical OfficerNASDAQ:TCRXTScan Therapeutics Inc
02/04/202408:00GlobeNewswire Inc.TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:TCRXTScan Therapeutics Inc
06/03/202418:11Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TCRXTScan Therapeutics Inc
06/03/202409:30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:TCRXTScan Therapeutics Inc
14/02/202418:45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TCRXTScan Therapeutics Inc
29/08/202309:02Dow Jones NewsTScan Gets FDA Clearance of Investigational New Drug Application for Cancer TreatmentNASDAQ:TCRXTScan Therapeutics Inc
24/07/202320:31Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TCRXTScan Therapeutics Inc
29/06/202309:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCRXTScan Therapeutics Inc
15/06/202319:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRXTScan Therapeutics Inc
12/06/202317:31Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TCRXTScan Therapeutics Inc
08/06/202314:26Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TCRXTScan Therapeutics Inc
06/06/202311:25Dow Jones NewsTScan Therapeutics Shares Rise 17% After FDA Clears IND for Cancer TreatmentNASDAQ:TCRXTScan Therapeutics Inc
02/06/202317:07Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TCRXTScan Therapeutics Inc
02/06/202317:07Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TCRXTScan Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:TCRX

Seu Histórico Recente

BOV
SEQL3
Sequoia Logistica e Tran... ON
BOV
COGN3
COGNA ON
BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados